THOMAS FOSTER
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology MOBILE, AL NPI 1992962856
Browse related groups: Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology AL ABBVIE INC. All categories
General Payments — all program years on this page
$52,636.13
- Category: General Payments
- Program years: PY2018–2024
- Record count: 568
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $156.04 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $156.04 | 9 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $54.55 | 3 |
| Amgen Inc. | $30.76 | 2 |
| PFIZER INC. | $25.41 | 1 |
| Janssen Pharmaceuticals, Inc | $15.36 | 1 |
| Medtronic, Inc. | $15.29 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $14.67 | 1 |
By program year
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1077906843 | Janssen Pharmaceuticals, Inc | $15.36 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1086915301 | Novartis Pharmaceuticals Corporation | $14.67 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1103745595 | ABBVIE INC. | $17.72 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1103745597 | ABBVIE INC. | $22.71 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1103745599 | ABBVIE INC. | $14.12 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1115631807 | Amgen Inc. | $15.94 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1115631817 | Amgen Inc. | $14.82 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1119584851 | Medtronic, Inc. | $15.29 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131354610 | PFIZER INC. | $25.41 | 04/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.